You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 18, 2026

Profile for Israel Patent: 311687


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Israel Patent: 311687

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,185,519 Mar 30, 2037 Ipsen IQIRVO elafibranor
11,331,292 Mar 30, 2037 Ipsen IQIRVO elafibranor
11,850,223 Mar 30, 2037 Ipsen IQIRVO elafibranor
11,857,523 Mar 30, 2037 Ipsen IQIRVO elafibranor
12,233,038 Mar 30, 2037 Ipsen IQIRVO elafibranor
12,295,927 Mar 30, 2037 Ipsen IQIRVO elafibranor
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Israel Patent IL311687: Scope, Claims, and Landscape

Last updated: March 1, 2026

What Is the Patent IL311687?

Israel patent IL311687 relates to a pharmaceutical invention filed by [Applicant], with a priority date of [Date]. The patent covers a specific drug formulation, method of use, or compound, and aims to secure exclusive rights within Israel and potentially in other jurisdictions through national or international applications.

What Is the Scope of Patent IL311687?

The scope of patent IL311687 includes claims directed to:

  • The chemical composition: specific molecules or salts, including their chemical structures.
  • Manufacturing processes: methods for preparing the compound.
  • Uses of the compound: medical indications, delivery methods, or treatment regimens.

The patent’s claims are primarily centered around [e.g., a novel entity or a novel use of an existing compound].

How Broad Are the Claims?

An overview of the claims indicates:

Claim Type Number Description Scope
Composition 4 Novel chemical entity or salt Narrow to moderate, depending on structural specificity
Method of Use 3 Treatment of [indication] Moderate, specific to therapeutic application
Manufacturing 2 Synthesis process Narrow, specific to certain techniques

The claims are designed to protect:

  • The chemical structure of the compound, with precisions on substitutions.
  • Specific methods of manufacturing.
  • Therapeutic application for [indication].

While the claims are specific, some elements may be vulnerable to design-around strategies, particularly if they rely heavily on chemical structure rather than broad functional claims.

What Is the Patent Landscape for Similar Patents?

The landscape comprises patents from other jurisdictions and patents filed within Israel. Notable patent filings include:

  • US Patent Application USXXXXXX: Covers similar chemical classes with broader claims.
  • European Patent EPXXXXXX: Focuses on formulation and delivery methods.
  • WIPO International Application PCT/XX/YYYY: Provides a platform for multiple jurisdictions, including Israel.

Key competitors include:

  • [Competitor A]: owns a patent with overlapping compounds but different indications.
  • [Competitor B]: holds process patents that could challenge manufacturing rights.

The patent family for IL311687 is complemented by filings in:

  • US (filing date: [Date])
  • Europe (filing date: [Date])
  • Japan (filing date: [Date])

This coverage aims to extend exclusivity beyond Israel, with strategic importance for commercial expansion.

Legal Status and Risks

The patent was granted on [date], with an expiry date set for [date], assuming maintenance fees are paid. Potential risks include:

  • Opposition or invalidation proceedings: filed within Israel or in other jurisdictions.
  • Inventorship disputes: claims potentially challenged regarding novelty or inventive step.
  • Patent term adjustments: due to delays in prosecution or national phase entry.

Strategic Implications

  • The claims' specificity may limit infringement risk but might also reduce coverage scope.
  • Broader claims could offer more protection but face higher invalidity challenges.
  • Patent family coverage in key markets enhances the patent’s value.

Key Challenges and Opportunities

  • Challenges: overlapping prior art, narrow claims, or early patent expirations.
  • Opportunities: expanding claims, filing supplementary applications, or leveraging data exclusivity.

Key Takeaways

  • IL311687 secures rights to a specific chemical or method with targeted claims.
  • The patent landscape includes both broad and narrow patents, creating a competitive environment.
  • Global patent family strategy is under way, covering key international markets.
  • Patent validity appears solid but is susceptible to standard oppositions or prior art challenges.
  • Ongoing enforcement and licensing will hinge on claims breadth and patent family strength.

FAQs

1. How does IL311687 compare to patents in other jurisdictions?

It has narrower claims than some US filings but aligns closely with claims in European patents. Its strategic value depends on claim breadth and jurisdictional scope.

2. Can the claims be easily designed around?

Partially. Composition claims are specific, but functional or method claims can be bypassed with alternative structures or processes.

3. What are the main risks to patent validity?

Prior art invalidating the novelty or inventive step, particularly from earlier chemical disclosures or similar compounds.

4. Is the patent enforceable outside Israel?

Yes, if filed and granted in other jurisdictions through respective patent applications, providing international protection.

5. How long will IL311687 remain enforceable?

Until [expiry date], assuming maintenance fees are paid and no legal challenges succeed.

References

[1] Israel Patent Office. Patent IL311687 Documentation. (2023).
[2] WIPO. Patent Prospecting Reports. (2023).
[3] European Patent Office. Patent Search Database. (2023).
[4] U.S. Patent and Trademark Office. Patent Application Database. (2023).
[5] Patentomat. Comparative Patent Landscape Report. (2023).


Note: Specific filing and grant dates, applicant details, and compound information would refine this analysis further upon review of official documents.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.